Immorta Bio Presents SenoVax™ Mediated Tumor Remission Data at International Biotechnology Conference

Posted on by

Scientific Longevity Company Provides Updates on its Oncology Program at LSX Investival Showcase MIAMI, March 13, 2025 /PRNewswire/ — Immorta Bio Inc., a scientific longevity company focused on “Treating Diseases of Aging and Treating Aging as Disease™,” announced today that its Chairman…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.